Showing results (211-220 of 266) with videos related to

Sort By:
Pageof 27
Journal of Clinical Medicine|January 23, 2024
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter AnalysisElena Pezzolo, Michela Ortoncelli, Silvia Mariel Ferrucci, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 19, 2023
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitorsMario Mandalà, Giuseppe Palmieri, Vienna Ludovini, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2020
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)Mario Mandalà, Francesca Galli, Roberto Patuzzo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 10, 2019
Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanomaAram Boada, Antonio Tejera-Vaquerizo, Simone Ribero, et al.
Dermatology and Therapy|June 5, 2026
Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate PsoriasisLuigi Gargiulo, Antonio Costanzo, Piergiorgio Malagoli, et al.
International Journal of Dermatology|April 12, 2024
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patientsGianluca Nazzaro, Andrea Carugno, Paolo Bortoluzzi, et al.
American Journal of Clinical Dermatology|June 15, 2023
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of ObservationAndrea Chiricozzi, Michela Ortoncelli, Donatella Schena, et al.
The Journal of Dermatological Treatment|January 6, 2025
Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world studyCarlo A Vignoli, Luigi Gargiulo, Luciano Ibba, et al.
Frontiers in Medicine|August 7, 2023
Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experienceMartina Merli, Martina Accorinti, Maurizio Romagnuolo, et al.
Archives of Dermatological Research|May 23, 2025
Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study-IL AD (Italian Landscape Atopic Dermatitis)Luca Potestio, Cataldo Patruno, Alessandra Narcisi, et al.
Pageof 27